نتایج جستجو برای: eluting stents

تعداد نتایج: 19304  

Journal: :The Canadian journal of cardiology 2013
Alexander A Leung Danielle A Southern P Diane Galbraith Merril L Knudtson Andrew C Philpott William A Ghali

BACKGROUND Previous research suggests that the early benefit from revascularization with drug-eluting stents might diminish over time. METHODS We performed an extended analysis of a previously identified cohort of 6440 patients who underwent percutaneous coronary intervention between April 1, 2003 and March 31, 2005 using a prospective provincial clinical registry in Alberta, Canada. We compa...

Journal: :Medicine 2016
Eun Young Ji Gyung-Min Park Dae Won Kim Tae-Seok Kim Chan Joon Kim Jung Sun Cho Mahn-Won Park Sung Ho Her

Stent fracture is an uncommon complication of drug-eluting stent implantation, but it has a clinical significance because of its potential association with adverse cardiac events such as in-stent restenosis, target lesion revascularization, and stent thrombosis. Multiple stent fractures account for a small proportion, but they may lead to more serious complications. Newer generation drug-elutin...

Journal: :Arquivos brasileiros de cardiologia 2011
Pedro José Negreiros de Andrade

1. Ribeiro EE, Ribeiro HB. Uso de stents farmacológicos na ‘vida real” : a importância dos registros. Arq Bras Cardiol. 2010; 95 (1): 131-4. 2. Kirtane AJ, Gupka A, Iyengar S, Moses JW, Leon MB, Applegate R, et al . Safety and eficacy of drug-eluting stents and bare metal stents: comprehensive meta-análisys of randomized trials and observational studies. Circulation. 2010; 119 (25): 3198-206. R...

2010
Alejandro Saez Raul Moreno

Bare metal stents enabled a reduction in the risk of early procedural complications and restenosis in comparison with balloon angioplasty alone, but introduced a new and device-specific iatrogenic condition, ie, in-stent restenosis due to increased neointimal hyperplasia. Sirolimus- and paclitaxel-eluting stents reduce restenosis and the need for new revascularizations in comparison with bare m...

2014
Stephan Windecker Stefan Stortecky Giulio G Stefanini Bruno R daCosta Anne Wilhelmina Rutjes Marcello Di Nisio Maria G Siletta Ausilia Maione Fernando Alfonso Peter M Clemmensen Jean-Philippe Collet Jochen Cremer Volkmar Falk Gerasimos Filippatos Christian Hamm Stuart Head Arie Pieter Kappetein Adnan Kastrati Juhani Knuuti Ulf Landmesser Günther Laufer Franz-Joseph Neumann Dimitri Richter Patrick Schauerte Miguel Sousa Uva David P Taggart Lucia Torracca Marco Valgimigli William Wijns Adam Witkowski Philippe Kolh Peter Juni

OBJECTIVE To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. DESIGN Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while maintaining randomisation. ELIGIBILITY CRITERIA FOR SELECTING STUDIES A strategy of initial ...

Journal: :Heart 2005
H C Lowe B James L M Khachigian

S irolimus eluting stents are associated with very low restenosis rates when deployed for single de novo native coronary lesions. These and other drug eluting stents are changing the face of interventional cardiology practice. A number of fundamental practical questions arise with the use of these novel stents, including the effects on in-stent restenosis (ISR) of overlapping stents, tandem ste...

Journal: :JAMA 2008
David J Malenka Aaron V Kaplan F Lee Lucas Sandra M Sharp Jonathan S Skinner

CONTEXT Although drug-eluting stents reduce restenosis rates relative to bare-metal stents, concerns have been raised that drug-eluting stents may also be associated with an increased risk of stent thrombosis. Our study focused on the effect of stent type on population-based interventional outcomes. OBJECTIVE To compare outcomes of Medicare beneficiaries who underwent nonemergent coronary ste...

2009
Zakir Shaik Khaja S Mohammed Adnan Siddiqi Ilyas Mohammed Timothy A Shapiro Thomas P Phiambolis

BACKGROUND The drug-eluting stents have decreased the incidence of instent restenosis compared to bare metal stents. But, the incidence of late and very late stent thrombosis has increased with the drug-eluting stents. CASE PRESENTATION We are here, reporting three cases of incredibly late instent thrombosis, each one occurring after more than 50 months of drug-eluting stent placement. CONC...

Journal: :JAMA 2005
Adnan Kastrati Julinda Mehilli Nicolas von Beckerath Alban Dibra Jörg Hausleiter Jürgen Pache Helmut Schühlen Claus Schmitt Josef Dirschinger Albert Schömig

CONTEXT In patients with de novo coronary lesions, drug-eluting stents have drastically reduced restenosis risk compared with bare metal stents and conventional balloon angioplasty. It is less clear whether drug-eluting stents are superior to conventional balloon angioplasty for the treatment of patients with in-stent restenosis. OBJECTIVES To assess if drug-eluting stents are a more effectiv...

Journal: :Lancet 2014
Thomas Pilgrim Dik Heg Marco Roffi David Tüller Olivier Muller André Vuilliomenet Stéphane Cook Daniel Weilenmann Christoph Kaiser Peiman Jamshidi Therese Fahrni Aris Moschovitis Stéphane Noble Franz R Eberli Peter Wenaweser Peter Jüni Stephan Windecker

BACKGROUND Refinements in stent design affecting strut thickness, surface polymer, and drug release have improved clinical outcomes of drug-eluting stents. We aimed to compare the safety and efficacy of a novel, ultrathin strut cobalt-chromium stent releasing sirolimus from a biodegradable polymer with a thin strut durable polymer everolimus-eluting stent. METHODS We did a randomised, single-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید